Home
Português
English தமிழ் Português 中文 Tiếng Việt Filipino ਪੰਜਾਬੀ Tradução automática — a versão em inglês é a versão oficial.

Saúde Óssea e Osteoporose Folheto

Esta página foi traduzida automaticamente e ainda não foi verificada por um médico. A versão em inglês é a versão oficial.

O que você está sentindo

Você pode notar dor no ombro que piora com o movimento. Colocar a mão atrás das costas para fechar o sutiã pode se tornar difícil. Guardar a camisa dentro da calça também pode parecer desconfortável ou doloroso. O desconforto frequentemente se intensifica à noite, dificultando o sono do lado afetado. Isso é comum mesmo se você tiver diminuição da densidade mineral óssea, que é um sinal de ossos mais fracos.

Apesar desses sintomas, muitos pacientes ainda obtêm excelentes resultados dois anos após a reparação artroscópica do manguito rotador. Este procedimento utiliza pequenas câmeras e instrumentos para reparar os tendões rasgados no ombro. Seu cirurgião avaliará sua situação específica para determinar a melhor abordagem. A osteoporose não deve impedir você de realizar esta cirurgia, pois as taxas gerais de complicações permanecem baixas. No entanto, ter osteoporose significa que você está em maior risco de complicações e reoperações um a três anos após a reparação.

Esteja ciente de que pacientes com osteoporose podem enfrentar uma maior chance de problemas médicos nos primeiros 90 dias após a cirurgia do manguito rotador em comparação com aqueles que têm ossos saudáveis. É importante discutir sua saúde óssea com sua equipe de cuidados. Baixas taxas de uso de medicamentos para osteoporose são observadas em pacientes que sofreram fraturas do colo do fêmur, mesmo quando as diretrizes recomendam tratamento. Abordar sua densidade óssea agora pode ajudar a apoiar sua recuperação e a função do ombro a longo prazo.

O que está realmente acontecendo

A osteoporose significa que seus ossos se tornaram fracos e frágeis. Pense em um osso saudável como uma colmeia densa. Na osteoporose, os buracos nessa colmeia aumentam de tamanho. Isso torna a estrutura quebradiça e mais propensa a fraturas. Você pode não sentir dor até que ocorra uma fratura. No entanto, ossos fracos também podem afetar a cicatrização das suas articulações após a cirurgia.

Por exemplo, se você tiver uma cirurgia no ombro, a osteoporose é um fator de risco para complicações e reintervenções aos 1 e 3 anos. Isso ocorre porque o osso precisa ser forte o suficiente para manter a reparação no lugar. Apesar desse risco, a osteoporose não deve ser considerada um motivo para evitar a reparação artroscópica do manguito rotador. As taxas gerais de complicações são baixas. Na verdade, pacientes com densidade óssea reduzida ainda podem obter excelentes resultados em 2 anos após esse procedimento.

É importante saber que a osteoporose pode aumentar o seu risco de outros problemas. Pacientes com osteoporose podem experimentar uma incidência maior de complicações médicas dentro do período global de 90 dias do que pacientes não osteoporóticos após a reparação do manguito rotador. Isso significa que você precisa de monitoramento cuidadoso nos primeiros três meses após a cirurgia.

Seu cirurgião pode usar técnicas específicas para apoiar a sua cicatrização. Para procedimentos na coluna, o cimento ósseo contínuo e o tratamento padronizado são garantias de bons resultados clínicos para a vertebroplastia percutânea. O volume injetado de cimento ósseo maior que 5,5 ml pode ser uma garantia de bons resultados clínicos para a vertebroplastia percutânea. Essas etapas ajudam a estabilizar o osso e reduzir a dor.

Também existem muitas maneiras de gerenciar a saúde óssea. Produtos naturais de medicina tradicional chinesa fornecem uma base teórica e experimental para o desenvolvimento de novos medicamentos e para a melhoria do manejo da osteoporose. A acupuntura mostra eficácia promissora na melhora dos sintomas da osteoporose primária como uma intervenção física na prática clínica. Além disso, otimizar o momento da administração de teriparatida pode orientar estratégias de dosagem personalizada para aumentar a formação óssea e reduzir o risco de fraturas na osteoporose.

Sua equipe de cuidados está trabalhando para manter seus ossos fortes. Um modelo de envelhecimento baseado na densidade óssea pode facilitar e apoiar o desenvolvimento de estratégias de medicina de precisão na prevenção e no manejo da osteoporose. Isso ajuda a adaptar o seu tratamento às suas necessidades específicas. A terapia sequencial anabólica seguida de anti-reabsortiva pode informar diretrizes de tratamento para populações pós-menopáusicas de alto risco. Essas abordagens visam construir novo osso e impedir que ele se decompõe muito rapidamente.

O que esperar

Seu prognóstico depende em grande parte de quão ativamente você e seu cirurgião gerenciam a saúde óssea. A osteoporose é uma condição na qual os ossos se tornam fracos e frágeis. Com o cuidado moderno, isso não é uma sentença de declínio inevitável. Novas abordagens, como o uso de exames de densidade óssea para personalizar seu tratamento, ajudam seu cirurgião a criar um plano exclusivo para você. Essa estratégia personalizada visa fortalecer seus ossos e reduzir o risco de fraturas.

Se você receber tratamento, o objetivo é reconstruir a força. Seu cirurgião pode recomendar medicamentos ou terapias específicas que incentivem o crescimento ósseo novo. Alguns pacientes também encontram alívio por meio de intervenções físicas, como a acupuntura, que pode ajudar a aliviar a dor e melhorar o conforto diário. A chave é a consistência. Quando o tratamento é bem gerenciado — como o uso da quantidade adequada de cimento ósseo para procedimentos na coluna —, você pode esperar resultados estáveis e positivos que apoiam sua mobilidade e qualidade de vida.

Se a osteoporose não for gerenciada, os riscos aumentam significativamente. Ossos fracos estão mais propensos a fraturas, o que pode levar a complicações graves. Por exemplo, pacientes com osteoporose frequentemente enfrentam uma maior chance de problemas médicos nos três meses seguintes a outras cirurgias, como a reparação do manguito rotador. No entanto, ter osteoporose não significa que você não possa realizar uma cirurgia. Muitos pacientes ainda alcançam excelentes resultados dois anos após procedimentos como a reparação do manguito rotador, mesmo com menor densidade óssea. A principal conclusão é que a osteoporose é um fator de risco, não uma barreira. Ela requer atenção cuidadosa para prevenir complicações e reoperações um e três anos após a cirurgia.

A recuperação é diferente para todos. Alguns dias podem ser mais fáceis do que outros. O caminho a seguir envolve monitorar de perto sua saúde óssea e seguir seu plano de tratamento. Ao permanecer proativo, você dá a si mesmo a melhor chance de manter a força e a independência. Seu cirurgião o guiará em cada etapa, garantindo que seu cuidado evolua conforme suas necessidades mudam.

Reviewed by Kieran Hirpara · 13 June 2026.

Want the clinical detail? Read the clinician version.

Talk to your treating clinician for advice specific to you.

For an appointment with the CQ Hand + Upper Limb team, ask your GP about a referral or visit www.cqupperlimb.com.

Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • A bone density based aging model may facilitate and support the development of precision medicine strategies in osteoporosis prevention and management [1].
  • Optimizing teriparatide administration timing may guide personalized dosing strategies to enhance bone formation and reduce fracture risk in osteoporosis [2].
  • Natural traditional Chinese medicine products provide a theoretical and experimental basis for the development of new drugs and the improvement of osteoporosis management [3].
  • Sequential anabolic-to-anti-resorptive therapy may inform treatment guidelines for high-risk postmenopausal populations [4].
  • Acupuncture shows encouraging efficacy in improving symptoms of primary osteoporosis as a physical intervention in clinical practice [5].
  • Machine learning application to hand radiographs represents a possible step toward more accessible, cost-effective, automated diagnosis and earlier treatment of osteoporosis/osteopenia [6].
  • Low rates of osteoporotic pharmacotherapy were seen in patients who had femoral neck fractures despite established guidelines [7].
  • Patients with osteoporosis may experience a higher incidence of medical complications within the 90-day global period than nonosteoporotic patients following rotator cuff repair [8].
  • Patients with decreased bone mineral density can still achieve excellent 2-year outcomes after arthroscopic rotator cuff repair [9].
  • Osteoporosis is a risk factor for complications and reoperations at 1 and 3 years after arthroscopic rotator cuff repair [11].
  • Osteoporosis should not be considered a contraindication to arthroscopic rotator cuff repair given overall low complication rates [11].
  • Continuous bone cement and standardized treatment for osteoporosis were guarantees of good clinical outcomes for percutaneous vertebroplasty [12].
  • Injected bone cement >5.5 ml might be a guarantee of good clinical outcomes for percutaneous vertebroplasty [12].

How It Works

  • Bone density-based aging models can facilitate and support the development of precision medicine strategies in osteoporosis prevention and management [1].
  • Acupuncture shows encouraging efficacy in improving symptoms of primary osteoporosis, supporting its use as a physical intervention in clinical practice [5].
  • Machine learning applied to hand radiographs represents a possible step toward more accessible, cost-effective, automated diagnosis and earlier treatment of osteoporosis/osteopenia [6].
  • Low rates of osteoporotic pharmacotherapy are observed in patients who have sustained femoral neck fractures despite established guidelines [7].
  • Patients with osteoporosis may experience a higher incidence of medical complications within the 90-day global period following rotator cuff repair than nonosteoporotic patients [8].
  • Patients with decreased bone mineral density can still achieve excellent 2-year outcomes following arthroscopic rotator cuff repair [9].
  • Current machine learning-based prediction models for postmenopausal osteoporosis without fractures demonstrate good discriminative ability but are generally characterized by a high risk of bias, a notable lack of calibration performance evaluation, and insufficient validation of clinical utility [10].
  • Genetically modified stem cell therapy is a safe and effective method that can significantly improve bone mineral density and bone volume/total volume in animal models of osteoporosis [13].
  • The prevalence of osteoporosis among postmenopausal women hospitalized for fractures in China is 76.9%, with prolonged menopause, vertebral fractures, and recent fracture history identified as key risk profiles [14].
  • Obesity-associated dyslipidemia drives bone mineral density loss partly through inflammation-mediated pathways, with key inflammatory cytokines significantly mediating lipid metabolism's impact on bone health [16].
  • Bone mineral density alone cannot predict early migration of tibial baseplates in cementless total knee arthroplasty [17].

What the Evidence Shows

Risk Prediction and Screening

  • A bone density-based aging model may facilitate precision medicine strategies in osteoporosis prevention and management [1].

Pharmacologic and Non-Pharmacologic Therapies

  • The efficacy of acupuncture in improving the symptoms of primary osteoporosis is encouraging for its use in clinical practice as a physical intervention [5].
  • Genetically modified stem cell therapy is a safe and effective method that can significantly improve bone mineral density (BMD) and bone volume/total volume (BV/TV) in animal models of osteoporosis [13].
  • Jintiange capsules are a good choice for patients with osteoporosis for relieving pain, improving BMD, improving activity function, and improving gait and preventing fracture [18].

Perioperative Outcomes and Complications

  • Despite established guidelines, low rates of osteoporotic pharmacotherapy were seen in patients who had femoral neck fractures [7].
  • In osteopenic and osteoporotic patients undergoing total joint arthroplasty, rates of 2- and 5-year postoperative complications were low and similar among patients who used proton pump inhibitors perioperatively and those who did not [15].
  • Bisphosphonate use in patients who have osteoporosis did not decrease the risk of periprosthetic fracture following total knee arthroplasty, but significantly lowered the incidence of all-cause revision at 2 years [20].

Surgical Efficacy and Technical Factors

  • Osteoporosis should not be considered a contraindication to arthroscopic rotator cuff repair [11].
  • Continuous bone cement and standardized treatment for osteoporosis were guarantees of good clinical outcomes for percutaneous vertebroplasty, and injected bone cement >5.5 ml might be a guarantee [12].

Practical Considerations

  • Bone density-based aging models may facilitate precision medicine strategies in osteoporosis prevention and management [1].
  • Machine learning applied to hand radiographs represents a step toward more accessible, cost-effective, automated diagnosis and earlier treatment of osteoporosis/osteopenia [6].
  • Low rates of osteoporotic pharmacotherapy were observed in patients with femoral neck fractures despite established guidelines [7].
  • Patients with osteoporosis may experience a higher incidence of medical complications within the 90-day global period following rotator cuff repair compared to nonosteoporotic patients [8].
  • Patients with decreased bone mineral density can achieve excellent 2-year outcomes after arthroscopic rotator cuff repair [9].
  • Machine learning-based prediction models for postmenopausal osteoporosis without fractures demonstrate good discriminative ability but are characterized by a high risk of bias, a notable lack of calibration performance evaluation, and insufficient validation of clinical utility [10].
  • Continuous bone cement and standardized treatment for osteoporosis are guarantees of good clinical outcomes for percutaneous vertebroplasty [12].
  • Injected bone cement volume greater than 5.5 ml might be a guarantee of good clinical outcomes for percutaneous vertebroplasty [12].
  • The prevalence of osteoporosis among postmenopausal women hospitalized for fractures in China is 76.9% [14].
  • Prolonged menopause, vertebral fractures, and recent fracture history are key risk profiles for osteoporosis in postmenopausal women hospitalized for fractures [14].
  • Rates of 2- and 5-year postoperative complications in osteopenic and osteoporotic patients undergoing total joint arthroplasty were low and similar among those who used perioperative proton pump inhibitors and those who did not [15].

Key Evidence

  • [L3] This approach may facilitate and support the development of precision medicine strategies in osteoporosis prevention and management. [1] (10.1186/s12891-025-09298-0)
  • [L2] This trial is expected to provide crucial insights into optimizing teriparatide administration timing, potentially guiding personalized dosing strategies to enhance bone formation and reduce fracture risk in osteoporosis. [2] (10.1186/s13018-025-06083-6)
  • [L4] This paper summarises recent research progress on natural TCM products in preventing and treating osteoporosis and provides a theoretical and experimental basis for the development of new drugs and the improvement of osteoporosis management. [3] (10.1186/s13018-025-05879-w)
  • [L1] This sequential anabolic-to-anti-resorptive therapy may inform treatment guidelines for high-risk postmenopausal populations. [4] (10.1186/s13018-025-06040-3)
  • [L1] The current evidence suggests that the efficacy of acupuncture in improving the symptoms of primary osteoporosis is encouraging for its use in clinical practice as a physical intervention. [5] (10.1186/s13018-025-05513-9)
  • [L2] The findings represent a possible step toward more accessible, cost-effective, automated diagnosis and therefore earlier treatment of osteoporosis/osteopenia. [6] (10.1016/j.jhsa.2024.09.008)
  • [L3] Despite established guidelines, low rates of osteoporotic pharmacotherapy were seen in patients who had femoral neck fractures. [7] (10.1016/j.arth.2025.07.028)
  • [L3] In addition, patients with osteoporosis may experience a higher incidence of medical complications within the 90-day global period than nonosteoporotic patient. [8] (10.1016/j.xrrt.2026.100723)
  • [L3] Patients with decreased bone mineral density can still achieve excellent 2-year outcomes. [9] (10.1016/j.jse.2025.02.011)
  • [L1] Current machine learning-based prediction models for postmenopausal osteoporosis without fractures demonstrate good discriminative ability but are generally characterized by a high risk of bias, a notable lack of calibration performance evaluation, and insufficient validation of clinical utility. [10] (10.1186/s12891-025-09385-2)
  • [L3] Overall rates of complication were low and osteoporosis should not be considered a contraindication to arthroscopic RCR. [11] (10.1016/j.jseint.2026.101678)
  • [L3] Continuous bone cement and standardized treatment for osteoporosis were guarantees of good clinical outcomes for PVP, and injected bone cement >5.5 ml might be a guarantee. [12] (10.1186/s12891-024-08153-y)
  • [L1] Genetically modified stem cell therapy is a safe and effective method that can significantly improve the BMD and BV/TV in animal models of osteoporosis. [13] (10.1186/s12891-025-08507-0)
  • [L4] This study reveals an alarmingly high prevalence (76.9%) of osteoporosis among postmenopausal women hospitalized for fractures in China, identifying prolonged menopause, vertebral fractures, and recent fracture history as key risk profiles. [14] (10.1186/s12891-026-09517-2)
  • [L3] In osteopenic and osteoporotic patients undergoing TJA, rates of 2- and 5-year postoperative complications were low and similar among patients who used PPIs perioperatively and those who did not. [15] (10.1016/j.arth.2025.07.067)
  • [L4] Obesity-associated dyslipidemia drives BMD loss partly through inflammation-mediated pathways, with key inflammatory cytokines significantly mediating lipid metabolism's impact on bone health. [16] (10.1186/s12891-026-09576-5)
  • [L4] Our results suggest that BMD alone cannot predict early migration of tibial baseplates. [17] (10.1016/j.arth.2026.03.014)
  • [L1] In terms of relieving pain, improving BMD, improving activity function, and improving gait and preventing fracture, JTG is a good choice for patients with osteoporosis (OP). [18] (10.1186/s12891-025-08694-w)
  • [L3] While bisphosphonate use in patients who have osteoporosis did not decrease the risk of periprosthetic fracture, it did significantly lower the incidence of all-cause revision at 2 years. [20] (10.1016/j.arth.2024.11.004)

References

[1] Unveiling risk factors and predicting osteoporosis through bone density based aging model: a community-based cohort in Guangdong, China. BMC Musculoskeletal Disorders. 2025. DOI: 10.1186/s12891-025-09298-0

[2] Timing optimization of teriparatide dosing for postmenopausal osteoporosis: a randomized controlled trial. Journal of Orthopaedic Surgery and Research. 2025. DOI: 10.1186/s13018-025-06083-6

[3] Natural traditional Chinese medicine products: emerging therapeutic targets for the treatment of osteoporosis. Journal of Orthopaedic Surgery and Research. 2025. DOI: 10.1186/s13018-025-05879-w

[4] Effectiveness of anabolic and anti-resorptive agents for preventing postmenopausal osteoporosis fractures: a systematic review and network meta-analysis. Journal of Orthopaedic Surgery and Research. 2025. DOI: 10.1186/s13018-025-06040-3

[5] Efficacy of acupuncture for primary osteoporosis: a systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery and Research. 2025. DOI: 10.1186/s13018-025-05513-9

[6] Application of Machine Learning to Osteoporosis and Osteopenia Screening Using Hand Radiographs. The Journal of Hand Surgery. 2025. DOI: 10.1016/j.jhsa.2024.09.008

[7] A Missed Opportunity? Osteoporosis Treatment Following Femoral Neck Fractures: Reducing the Risk of Secondary Hip Fracture. The Journal of Arthroplasty. 2026. DOI: 10.1016/j.arth.2025.07.028

[8] Impact of osteoporosis on post-operative outcomes following rotator cuff repair. JSES Reviews, Reports, and Techniques. 2026. DOI: 10.1016/j.xrrt.2026.100723

[9] No difference in 2-year outcomes of arthroscopic rotator cuff repair in patients with osteoporosis. Journal of Shoulder and Elbow Surgery. 2025. DOI: 10.1016/j.jse.2025.02.011

[10] Risk prediction models for postmenopausal osteoporosis: a systematic review and meta-analysis study. BMC Musculoskeletal Disorders. 2026. DOI: 10.1186/s12891-025-09385-2

[11] Osteoporosis is a risk factor for complications and reoperations at 1 and 3 years after arthroscopic rotator cuff repair. JSES International. 2026. DOI: 10.1016/j.jseint.2026.101678

[12] Continuity and volume of bone cement and anti osteoporosis treatment were guarantee of good clinical outcomes for percutaneous vertebroplasty: a multicenter study. BMC Musculoskeletal Disorders. 2025. DOI: 10.1186/s12891-024-08153-y

[13] Genetically modified stem cells for osteoporosis: a systematic review and meta-analysis of preclinical studies. BMC Musculoskeletal Disorders. 2025. DOI: 10.1186/s12891-025-08507-0

[14] How prevalent is osteoporosis in a high-risk subgroup? A multicenter study of postmenopausal women hospitalized for fractures in China. BMC Musculoskeletal Disorders. 2026. DOI: 10.1186/s12891-026-09517-2

[15] Effects of Perioperative Proton Pump Inhibitor Use on Outcomes of Total Joint Arthroplasty Patients Who Have Osteoporosis and Osteopenia. The Journal of Arthroplasty. 2026. DOI: 10.1016/j.arth.2025.07.067

[16] Perioperative inflammatory cytokines nursing screening test indicate the link between dysregulated lipid metabolism and reduced bone mineral density in obese osteoporosis patients: a retrospective study. BMC Musculoskeletal Disorders. 2026. DOI: 10.1186/s12891-026-09576-5

[17] Stable Fixation in Cementless Total Knee Arthroplasty Even for Low Local Bone Mineral Density. The Journal of Arthroplasty. 2026. DOI: 10.1016/j.arth.2026.03.014

[18] The effect of Jintiange capsules on pain in patients with primary osteoporosis: a systematic review and meta-analysis. BMC Musculoskeletal Disorders. 2025. DOI: 10.1186/s12891-025-08694-w

[20] Bisphosphonate Use in Patients Who Have Osteoporosis Does Not Increase the Risk of Periprosthetic Fracture Following Total Knee Arthroplasty. The Journal of Arthroplasty. 2025. DOI: 10.1016/j.arth.2024.11.004

AfiliaçõesO que isso significa? →